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Hemodynamie stress testing was performed in four calves with a
chronically implanted left ventricular assist device consisting of a
double-valved pump interposed between the left vertricatar apex
and the descending thoracic aorta . The device was powered either
pneumatically (n = 1) or with a transcntanenus energy transmis-
sion system (n= 31. ffemodynamic evaluation (cardiac output and
right and left ventricular and pulmonary and carotid artery
pressures) was carried out at baseline and during all hemodynam-
ically stressed states.
Atria) pacing and ventricular pacing to a heart rate of 140
bealnlmin resulted in no significant change in right or left heart
filling pressures or cardiac output . Preload reduction with nitro-
prusside or transient inferior vena ova balloon occlusion resulted
in a marked decrease in left ventricular pressure vita p- a .
Early studies by Bernhard et al . Ill denmnslreted the clinical
utility of long-term left ventricular bypass with the use of a
pneumatically actuated, double-valved pump that was inter-
posed between the left ventricular apex and the ascending
thoracic aorta
. Successful use of the system has been
documented in calves for periods of up to 14 months . This
assist system has also been successfully used for short-term
hemodynamic support in selected patients after open heart
surgery (2-S).
A goal of left ventricular assist device research has peen
the eventual development of a totally implantable, telher-
free . electrically powered system for long-term implantation
in ambulatory patients with irreversible left ventricular dys-
function . Effective utilization of such a device requires
reliable loner term operation with the ability to respond
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arterial pressure. Phenytephrine administration
resulted to a marked evv 4a mean arterial pressure with no change
in cardiac output or filling pressure. Induction of ventricular
fibrillation resulted in a decrease of mean left ventricular pressure
to I I ± 8 mm He, but mean arterial pressure was maintained at
c50 men Hg,
It is concluded that a mutlicomponent, implantable, electri-
cally powered assist system is capable of maintaining a normal
cardiac output under"a wide range of trading conditions and
chrunotrrpir elates . Although this device is clearly prelosd depen-
dent . it capable of maintaining normal systemic pressures
during conditions of severe left ventricular dysfunction and circu-
latory collapse.
U Am Colt Cardial 1991 ;18:1779-8u)
appropriately to acute hemodynamic stresses, including
abrupt changes in heart rate . rhythm . preload . ifterload and
native left ventricular function . This report describes the use
of such a system in calves, employing a pusher-plate blood
pump, energy converter and controller, all completely im-
planted and electrically actuated through a transcutaneous
energy transmission system . The hemodynamic perfor-
mance of the electrically powered system implanted in three
healthy calves is described in response to acute circulatory
stress . and compared with results in a fourth calf with a
similar device driven by an external pneumatic power
source .
Methods
Dr .rtv'iplio i of rite left Ventricular
Assist Sv .1'ti'llt
The multicumponent ventricular assist system that has
been developed is an electrically actuated device consisting
of a pusher plea blood pump and Dacron-valved conduits
coupled to a low speed torque motor (Thermedics) . An
internal. variable volume chamber attached to the motor
assembly serves as a reservoir for air displaced dunn,t -ach
pump cycle . Synchronization of the system with (n- -Its
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provided by a conoollerlinternal energy storage unit . A
transcmaneous energy transmission -ystem conducts clew
trical power to the motor across intact skin, eliminating the
need for percutaneous tubes or wires with their attendant
hazard of infection .
Blood pump and contiguous energy converter . The push-
er-plate pump (maximal Stroke volume 85 ml) and an integral
electromechanical energy converter (weight 0 .87 kg) are
capable of ejecting a pulsatile flow (in vitro) of 10 liters/min
(mean) at a maximal rate of 140 heats1mai . The rigid pump
housing and energy converter were fabricated from tita-
nium alloy, and contain a flexible, polyurethane diaphragm
(biomes) that isolates one component from the other. Up-
ward displacement of the diaphragm by the motor produces
systolic ejection ; diastolic filling occurs during passive recoil
of the diaphragm . The diaphragm has a textured . fibrillar,
blood-contacting surface (mat thickness of 350 µm) to attract
and hind a thin fibrin-cellular coagulum . The internal surface
of the adjacent pump housing is covered by a powdered
metallurgy layer consisting of masses of interconnected
titanium microspheres, each approximately 140 µm in diam-
eter, This lining functions in a manner similar to the fibrillar
diaphragm, and also attracts a fibrin-cellular coagulant (6)
.
The low-speed torque motor operates on a beat to heat
basis and has only four moving parts . On receipt of an
ejection signal. the rotor of the unit turns one revolution and
slops (systolic ejection). The motor contains solid state
electronic commutation, and a magnet mounted on the
pusher-plate plus a sensor (located in the center shaft of the
rotor) permits monitoring of pusher-plate position
. This
electronic technique provides a measurement of stroke vol-
ume and plate velocity fur monitoring the ventricular assist
system performance.
Variable volume chamber. In the absence of an external
vent (between the motor and the external environment), a
chamber is used to maintain a constant gas volume within
the motor during systolic ejection and diastolic filling . The
chamber consists of a rigid backplate and a flexible IBiomer-
Butyl elastomer) discoidal sac covered with Dacron velour
fabric. The presence of a velour layer promotes formation of
a thin capsule at the sac surface in contact with the visceral
pleura (left lung). During ventricular ossi'l system function,
the chamber inflates with air as blood flows into the pump,
and deflates into the motor section during synchronized
ejection of blood . 'fh7; fibrous capsule inhibits formation of
thick pleural adhesions that could restrict motion of the
chamber and limit pump function .
Control system/internal energy storage unit . The control
unit is encased in a titanium housing and consists of three
interconnected printed circuit boards, 3 .8 cm in diameter.
Ten nickel-cadmium batteries are included in the housing,
forming a battery of 4 .5-watt-hours (w-h) capacity to supply
8 W of power. The batteries constitute an emergency
back-up capability for the ventricular assist system in the
case of power failure, and have a discharge time in excess of
40 min .
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Three operating triodes are possible Ivithin the controller :
synchronous counterpulsation, fixed volume asynchronous
pumping and fixed rate operation . Synchronization of the
device whet: implanted in patients is accomplished by de-
tecting changes in pump fill rate, corresponding to the rate of
descent of the pusher-plate (after ventricular systole) . Elec-
trocardiographic (ECG) signals are not tronitored because of
the inherent potential for fatiguedracture of myocardial
leads. In the calves used in this experimental model, the
large stroke volume of the ventricle may lead to early filling
of the device chamber, before completion of ventricular
systole, thus disrupting the timing of counterpulsation.
Therefore, ECG signals were used (in this experiment) to
adjust timing of device ejection during synchronous counter-
pulsation . Device liming was also manipulated by means of
the ECG to observe the effects of synchronous copulsation,
when the native ventricle and the left ventricular assist
device ejected simultaneously .
Transcutaneous energy transmission system . The transcu-
laneous energy transmission system consists of a power
oscillator, a tuned, transcutaneous transformer and output
power-conditioning circuitry . The oscillator converts direct
current power from external batteries to alternating current
160 krfz . During pump function, AC current is conducted to
a superficial primary coil on the external chest wall and
inductively coupled to an implanted, subcutaneous, second-
ary coil . High frequency magnetic fields are capable of
transmitting power through an unbroken layer of skin up to
1 .5 cm in thickness and are approximately 75% efficient .
External battery capacity and power requirements
. The
external battery power source, carried in a body harness or
belt, provides 10 h of pump function at a minimal flow rate of
7.0litersimin . 120-mm Hg mean pressure . Blood flow of this
magniude constitutes a 5-W power drain . This power has
added to it the 1 .7 W necessary for implanted electronics and
internal battery charging. Additional small power losses are
incurred in transferring energy across the intact skin, result-
ing in a total power requirement of 7
.8 W 110 h of operation)
.
Batteries must be replaced with an alternate unit every 8 to
10 h and recharged with use of a recharger unit powered
from a conventional ,11 outlet .
Surgical Implantation Method (Fig . 1)
The pusher-plate pump, controller and other components
of the electrical ventricular assist system were positioned
through a left thoracotomy incision and a separate left
subcostal labdominal) incision . The pump housing and con-
troller were attached with sutures to the 9th and Win ri'os
(subdiaphragmatic location), and the secondary TET coil
was implanted in a subcutaneous pocket adjacent to the 9th
vertebra posteriorly to permit induction of electrical AC
current .
Two bioprosthetir valved conduits (itJhnr and otdflou)
.
coupled to the blond ptunp, were connected to the left
ventricular apex and descending thoracic aorta (end to side
IACi Vol . 18 . N . .7
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Figure L Illustration of left ventric-
ular assist device components and
surgical implantation in schematic
form (top( and in intact calf (bat.
tom) . See text for details .
anastomoses) through short incisions in the left hemidia .
phragm (Fig. 1)
. Maximal blood flow to the pump was
attained by advancing the titanium infuse cannula into the
left ventricular chamber to the base of the po,terolateral
papillary muscle (mitral valve) . Thi, position prevented
encroachment on the lumen of the cannula by either the Icft
ventricular free wall or the interventricular septum
. The
variable volume chamber . connected by a cable to the motor
houslttg. was placed in the left pleural space, and fixed in
position with sutures fifth and sixth rihsl .
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Hem,aJvtumie Stress Testing ?f the Left
Vrrttricrdetr Assist Svstetrt
Study animals
. After surgical implantation of the left
ventric°ular assist system . calves recovered uneventfully
with routine postoperative care. The system was activated
immediately after implantation and kept continuously active
thereafter
. The left ventricle of calves receiving the assist
system was normal and not rendered dysfunctional, and the
assist system functioned by filling at the normal left ventric-
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ularpreload (see Results) . Four calves with an implanted left
ventricular assist system, powered either pneumatically In =
I) or with a transculaneous energy transmission system In =
31
. were studied with right and left heart catheterization a
mean of 4 *- 2 weeks after surgical implantation . At the time
of study, the average weight of the calves was 102 ± 3 kg . In
all animals
. surgical cutdown of the right internal jugular
vein and right carotid artery was performed with placement
of SF sheaths in both vessels . Right heart catheterization
was performed with a 7F balloon-tipped Swan-Ganz catheter
advanced to the pulmonary artery . A 7F pigtail catheter
instrument with a 2F Millar micromanometer catheter was
used for left heart catheterization and catheterization
through the inflow conduit, pump and outflow conduit of the
left ventricular assist system .
Hemudynamic stresses . Atrial and ventricular pacing
were performed with a 7F USCI bipolar pacer. Inferior venal
cava occlusion was performed with placement of a 40-mm
occlusion balloon in the inferior vena cava . Changes in
prcload and afterload were achieved with administration of
nitroprusside and phenylephriac . Pump function was also
examined during spontaneous or induced ventricular fibril-
lation . Results are reported as mean values *- SD .
Results
Baseline hemodynatnic evaluation . The left ventricular
assist pumps were operated in one of three modes doting
these experiments (Fig. 2) . In mode 1 . synchronous copul-
sation . the pump ejects in conjunction with ventricular
systole . In mode 2, synchronous countzrpulsalion . the
stroke volume of the pump is ejected just after the peak of
left ventricular systolic pressure. with the pump generating
pressure throughout most of ventricular diastole . In mode 3,
tACC Vul. 18, Ne . 7
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Figure 2. txft ventricular and arte-
rial pressures in the four calves with a
chronically implanted left ventricular
assist device )LVAD) . illustrating the
different modes of operation. In
mode I )LVAD U, synchronous co
pulsation, the pump ejects in con-
junction with left ventricular (LVI
systole . In mode 2 (LVAD 2 and
LVAD 4), synchronous counterpul-
sation . the stroke volume of the
pump is ejected just after the peak of
left ventricular systolic pressure,
with the pump generating pressure
throughout most of ventricular dias-
tole . In mode 3 (LVAD 31. fixed
volume asynchronous pulsation, the
pump operates at a fixed rate and is
not coordinated with left ventricular
contraction . Note that in cal` 3
(LVAD 3), total circulatory suppun
is proviled by the left ventricular
assist
d
evice. C A
= carotid artery :
ECG = electrocardiogram.
fixed volume asynchronous pulsation, the pump operates at
a fixed rate and is not coordinated with left ventricular
contraction .
Baseline right and left heart catheterization was per-
formed in the four calves (average weight 102 ± 3 kg) . In the
first calf, in which the left ventricular assist device was
powered by an external pneumatic pump, right atrial pres-
sure was 3 mm Hg, right ventricular pressure 25/2 mm Hg,
pulmonary artery pressure 25112 (mean IS) mm Hg, mean
pulmonary capillary wedge pressure 6 mm Hg, left ventric-
ular pressure 17316 mm Hg, and systemic pressure 1821155
(mean 162) mm Hg . Rest cardiac output was 7 .5 liters/min
and systemic vascular resistance and pulmonary vascular
resistance were 1,696 and 96 dynes's'cm -`, respectively .
In Cah- 2, 3 and 4 . the left ventricular assist device was
an electrically driven device with a transculaneous power
source
. The average baseline hemodynamics in these three
calves included a mean right oral pressure of 8 mm Hg,
right ventricular pressure 34/8 mm Hg, pulmonary artery
pressure 34 :1 7 (mean 241 mm Hg, mean pulmonary capillary
wedge pressure 14 mm Hg. left ventricular pressure
107/15 mm Hg and systemic pressure 143/108 (mean 120) mm
Hg . Rest cardiac output was 8 .4literslmin and systemic and
pulmonary vascular resistance values were 1,067 and 96
dynes'n cm` . respectively .
Cat/leterization of the left vearrirolar assist device in all
four
valves revealed a physiologic gradient across the distal
outflow conduit, with a mean 38-mm Hg gradient in systolic
pressure from the pump chamber to outflow vessel laortal
(Fig. 3), Note that during diastole, a negative diastolic
pressure is recorded that may be responsible for preferential
filling of the left ventricular assist device (versus the left
ventricle) .
JACC V.I . 19. Nn. 7
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Figarx 3. Demonstration of pressure gradient from the left ventric-
.'ar assist device (LVAD) pump chamber to the aorta (here equal to
the carotid artery (CAI) for modes I and 2 . The average peak
systolic gradient for the four calves was 38 met Hg . Note that a
negative pressure is generated by the left ventricular assist device
during diastole, which may be responsirle for preferent :nl filling of
the left ventricular assist device (versus the left ventricle),
Inferior versa Lava occlusion . Marked reduction in yen .
tricular preload was successfully achieved in the three calves
with the electrical left ventricular assist device by transient
occlusion of the inferior vena cava (Fig . 4) . At peak inflation .
left ventricular systolic pressure decreased to an average of
:4 ± 25 mm Hg
. Yeload dependence of the pump system is
illustrated by the progressive decrease in arterial blood
pressure during interior vena cava obstruction. However .
arterial pressure stabilized at 97 ± 21 152 -_ 12 mm Hg . The
marked effect of inferior vena cava occlusion on left ventric-
ular pressure suggests that the reduced venous return arriv-
ing at the left atrium is preferentially shunted to the left
ventricular assist device, which has the capability of gcccr-
ating diastolic suction (Fig . 3).
Nitroprusside administration. This resulted in a 60-mm Hg
decrease in mean systemic arterial pressure from baseline .
Cardiac output decreased from 7 .5 to 4.8literslmin in the calf
with the pneumatic device and from 8.4 to 6
.6 liters/min in
two calves with the electrical device .
Atrial and ventricular pacing . Successful atrial pacing
was performed in the four calves . with a mean, increase in
heart rate to 140 beatsimin . With both the pneumatic and the
MCKAY ET AL.
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ciectrical d
evices . n o significant difference was noted in
pulmonary artery pressure, pulmonary capillary wedge pres-
sure. carotid artery pressure
. mean arterial pressure, ther-
modilution cardiac output, systemic vascular resistance and
pulmonary vascular resistance during pacing tachycardla .
The contribution of the left ventricular assist system contin-
ued to b substantial, as inferred from the persistent support
of aortic pressure higher than left ventricular systolic pres-
sure
. Similar results were noted with ventricular pacing .
Phenylephrine administration . Administration of phecyl-
ephrine resulted in a 35 to 60 mm Hg increase in peak
systolic and mean arterial pressures with an accompanying
increase of ( mm Hg in mean pulmonary capillary wedge
pressure in the four calves
. Peak systolic aortic Pressure
exceeded left ventricular pressure in all cases, with antic
dio ,aoh, pressure matching left ventricular systolic
Pr1s=ere
in the three calves with the electrical device, again indicating
that the left ventricular assist device was generating sys-
temic pressure .
Induction of ventricular fibrillation . In three calves, he-
modynamic measurements were made after 20 min of ven-
tricular fibrillation
. Examples of support of systemic arterial
pressure by the left ventricular assist device during ventric-
ular fibrillation are shown in Figure 5
. Note the marked
effect of mean left ventricular pressure on the ability of the
pump to generate aortic systolic and diastolic pressures
.
implying that even in ventricuiar fibrillation volume loading
could restore on effective cardiac output .
Autopsy. Animals were killed at the end of the hemody-
namic protocol . There was no evidence of thromboembolism
within the left ventricular assist device or its connections
with the heart and z rrta, nor were there any other compli-
cations associated with the device or its electrical control
system .
Figure 4. Preload dependence of the left ventricular assist device is
demonstrated by inferior vena can, balloon occlusion in Calf 3
lasvnchmnous mode)
. Note the maintenance of carotid artery (CAI
pressure m
90150
mm Hg despite the complete abolition of left
ventricular I IN I pressure. The marked effect of inferior vena cava
occlusion on left ventricular pressure suggests that the reduced
venous return arriving at the left atrium is preferentially shunted to
the left ventricular assist device, which has the capability of
generating diastolic suction (see Fig . 3).
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Discussion
A significant limitation of this study is the small number
of experimental subjects. each of which was subjected to
multiple interventions during the course of hemodyn4mic
study . Statistical analysis of rile diferenees in hemodynamic
variables is prevented by the small number of animals tested
.
but the combined cost of approximately $100000 per exper-
iment (for the animal
. housing, the left ventricular assist
device, hemodynamic testing and other factors) precluded a
larger study
. Within the context of this limitation the elec-
trical system described here has the advantage of being
mildly implantable and tether free, to permit permanent
implantation in ambulatory patients with irreversible left
vcntricuh:r dysfunction.
Previous studies. Early studies by Bernhard et al . 111
demonstrated that a temporary
. pneumatic double-valved
device, interposed between the ventricular apex and aorta .
can augment or replace native cardiac output while reducing
left ventricular peak pressure and myocardial energy con-
sumption . That early system suffered from the disadvantage
of requiring an external pneumatic control system to drive
the implanted device by way of a percutaneous tube . Inves-
ligation of the use of assist systems to aid left heart pumping
dates back to the 19609 (7). with most initial designs com-
prising a paracorporeal pump connected by catheters to the
:cft atrium and descending aorta, and employing an extra-
corporeal pneumatic driving unit
. Many current implantable
pi,rop systems aow use the left ventricular apex as the site of
the pump inflow port
.
Pennock et al, (0) to 1979 noted that experimental acute
infarct size in dogs with left ventricular assist device place-
ment using ventricular connotation was significantly lens
than that in control animals witheut an assist device . The
physiologic advantages of a left ventricular assist system
were also demonstrated by Mickleborough et al . (9) . using a
canine model of left ventricular failure caused by normo-
thermic ischemic arrest
. A comparison of the left ventricular
assist device versus a combination of inotropic drugs and
intraaurtic balloon counterpulsation showed satisfactory he-
t A
J
~
_\
Figures . Leftventricul :vassisldrvice(LVADlsuppon
	 - during ventricular fibrillation in 1% espLriments
I LV .AD I and LVAD 2I
. Note the preservation of
carotid artery (CA) pressure during l
ass
of left ventric.
/eL ular (LV) pressure . Pulmonary artery (PAP pressure is
also shown . At higher right heart, pulmonary artery and
left ventricular pressures (right
panel.
the left ventsic-
nh:r assist device is uhle to produce a normal amorist
blood pressure .
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mod, amic support in each case. but the heart of those dogs
treated with the left ventricular assist device had signifi-
cantly less decrease in compliance and systolic function and
less myocardial necrosis on histologic examination
. The
electrically powered. chronically implanted device profiled
in the present report was able to provide continued circula-
tory support despite a variety of acute hemodynamic
stresses, and its performance was comparable to that of a
device that used an external pneumatic pump as power
source . Moreover, as opposed to dogs
. the large animals
(average weight Ill' m 3 kg) used in our study have a
circulatory requirement equal to or greater than those of
humans.
Baseline hemodynamic values
. At baseline. hemodynamic
variables were notable for systemic diastolic hypertension in
these calves after general anesthesia and instrumentation,
Total cardiac output . reflecting the combined output of the
native heart and the assist device
. was approximately 0
liters/min in the unstressed state . Peak systolic left ventric-
ular pressure was at or below mean aortic pressure, suggest-
ing that the majority of circuiatory support was being fur-
nished by the left ventricular assist device . The left
ventricular pressure was reduced most dramatically in com-
parison with aortic pressure when the pump was operated in
the ;synchronous mode as seen in Figure 2 for Calf 3
(electrically powered)
. This finding is consistent with the
work of Nakamura et al . 110) . who neted that mean aortic
pressure and total flow were highest in a 1 :l synchronous
pumping mode, whereas asynchronous pumping was more
useful in reducing mechanical work of the left ventricle .
Alrial or ventricular pacing and phenylephrine . Pacing at
rates up to 140/min produced a slight decline in systemic
arterial and left ventricular pressures, with only small
changes in pulmonary capillary wedge pressure and cardiac
output. While in the synchronous mode. both the electrical
and the pneumatic devices could track appropriately 1 :1 at
an atrial paced rate of 1411/min . Afterload augmentation with
phenylephrine appropriately elevated systemic arterial pres-
sure . but cardiac output and left ventricular cnd-diaatctic
IACC Vol
. 18,
No.
7
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pressure were unchanged
. This observation suggests contin-
ued adequate forward ejection by the pump despite an acute
rise in afterload, with minimal evidence of retrograde trans-
mission of elevated pressure .
Nitroprussida administration and inferior vena cave occlu-
sion. Nitroprusside markedly lowered left ventricular and
systemic arterial p ressures. a s expected. Left ventricular
end-diastolic pressure decreased as did cardiac output de-
spite appropriate reflex tachycardia . This diminution in flow
underscores the preload dependency of the left ventricular
assist device : because the pump chamber accepts blood from
the left ventricle . pump filling is critically sensitive to reduc-
tion in left ventricular filling pressure . This preload depen-
dency was demonstrated even -nor,, dramatically by inferior
vena cava balloon occlusion
. Systemic arterial pressure
decreased rapidly but was maintained at an average of
97152 mm Hg. whereas left ventricular pressure was virtually
obliterated (Fig . 4). This stabiiization of systemic arterial
pressure despite the lack of significant developed left ven-
tricular pressure suggests that although both chambers are
highly preload dependent, the left ventricular assist device
pump may fill preferentially (to the left ventricle) when
preload is reduced.
Ventricular fibrillation . During ventricular fibrillation.
the support of the circulation by the pneumatic and electric
left ventricular assist device were comparable.
with
systemic
arterial pressure ranging from 85/50 to 130190 mm Hg I Fig . sit
and cardiac output from 2 .5 to 2.7 literlmin despite the
virtual absence of developed left ventricular pressure . These
findings again demonstrate the limitations of preload depen-
dency for these devices which assist only the left ventricle .
While the continued evacuation of the left ventricle by the
left ventricular assist device and forward ejection of blood
into the systemic arterial circulation limit the increase in
left-sided filling pressures and pulmonary congestion, coex-
istent
right ventricular failure prevents optimal filling of the
left ventricular assist device pump chamber from he left
ventricle . However, the ability of this device to maintain
adequate perfusion pressure and a low cardiac output in
these states of minimal or absent remricular function indi-
cates that some degree of effective filling must still occur,
with negative pressure developed by the left ventricular
assist device a potential source of augmented pump filling in
these conditions. Limitation of pulmonary congestion and
right ventricular dilation was documented by postmortem
examination in these animals, which died from irreversible
ventricular fibrillation induced as part of the study protocol
(electrical defibrillation was not possible in these closed
chest animals because of the high electrical resistance of
their thick hides). Some pulmonary congestion and right
ventricular dilation were seen I ;1 these calves, but they were
minimal . The influence of left ventricular assist devices on
right ventricular function has been shown to he favorable in
recent studies (11 .12).
Clinical implications
. The clinical benefits of mechanical
left ventricular assistance have been shown by many inves-
M,KAY ET AL
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tigators who have assessed its role in the management of
cardiogenic shock after aortocoronary bypass or valve re-
placement surgery (2-5 .13-15), in Scale falminant myocardi-
tis (16) and as a "bridge' - to cardiac transplantation (17 201
.
Thromboembolic complications of left vehtricular assist
devices are rare 113
.19), particularly with the
se of a
textured blood-contacting surface that promotes neointimal
development )20) .
as in the device utilized in the present
study.
Conclusions . A totally implantai' e . electrically powered
left ventricular a,sist system is capable of maintaining a
normal cardiac output under a bread range of loading con-
ditions in a large animal (average weight 102 ± 3 kg) with
circulatory requirements similar to those of humans . "fhe
function of the tether-free electrical left ventricular assist
device evaluated here in responoc !o acute hemodynamic
stress is wholly comparable to that of a device using an
external pneumatic pump as power source . Although clearly
preload dependent. the device can effectively support sys-
temic arterial pressure at near normal levels during condi-
tions of severe hemodynamic stress and circulatory collapse .
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